Gyl Financial Synergies, LLC Gsk PLC Transaction History

Gyl Financial Synergies, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$42.05 - $47.77 $264,788 - $300,807	-6,297 Closed	0 $0
Q1 2022 May 05, 2022	BUY	$40.23 - $47.74 $253,328 - $300,618	6,297 New	6,297 $274,000
Q3 2020 Nov 06, 2020	SELL	$38.11 - $42.99 $200,763 - $226,471	-5,268 Closed	0 $0
Q2 2020 Aug 04, 2020	BUY	$37.87 - $43.58 $199,499 - $229,579	5,268 New	5,268 $215,000
Q1 2020 May 05, 2020	SELL	$32.47 - $48.83 $180,598 - $271,592	-5,562 Closed	0 $0
Q4 2019 Feb 06, 2020	BUY	$42.0 - $48.25 $28,728 - $33,003	684 Added 14.02%	5,562 $261,000
Q3 2019 Nov 12, 2019	SELL	$40.46 - $43.52 $1.57 Million - $1.69 Million	-38,828 Reduced 88.84%	4,878 $208,000
Q1 2019 May 14, 2019	BUY	$38.57 - $42.69 $1.69 Million - $1.87 Million	43,706 New	43,706 $1.83 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $68.5B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Gyl Financial Synergies, LLC, based on Form 13F filings with the SEC.

Stay updated on Gyl Financial Synergies, LLC with notifications on news.